This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Includes the Inaugural North American Viral Hepatitis Elimination Summit

2020 PROGRAM

Sunday, March 1, 2020

7:00 - 8:00 AM
CASL Special Interest Group Meetings

7:00 - 7:30 AM
CAHN Breakfast

7:30 - 9:30 AM
CAHN AGM

8:00 - 9:00 AM

SYMPOSIUM (BEST OF AASLD)

Hemant Shah, UHN

  • NAFLD, Giada Sebastiani, McGill University
  • Portal Hypertension / Cirrhosis, Andrew Aronsohn, University of Chicago
  • Alcohol, Phillipe Mathurin, INSERM
  • HCV, Amit Singal, UT Southwestern Liver Centre

9:00 - 10:30 AM
ORAL ABSTRACT PRESENTATION

Keith Tsoi, McMaster University & Cynthia Tsien, University of Ottawa

  • Women Likely to Benefit from Having a Potential Living Liver Donor Compared to Men, Mamatha Bhat, UHN
  • Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis, Gideon Hirschfield, UHN
  • Preventive Effect of Celecoxib in Sorafenib-Related Hand-Foot Syndrome in Hepatocellular Carcinoma Patients, a Single-Center, Open-Label, Randomized, Controlled Clinical Phase III Trial, Jiancong Chen, First Affiliated Hospital, Sun Yat-Sen University
  • Noninvasive Tests (NITs) May More Accurately Quantify Fibrosis than Liver Histology in Patients with Advanced Fibrosis Due to NASH, Keyur Patel, UHN
  • Health-Related Quality of Life – a Rapid Independent Predictor of Hospitalizations and Mortality in Cirrhosis, Beverley Kok, University of Alberta Hospital
  • Hemojuvelin Deficiency Predisposes Mice to Hepatocellular Carcinoma, Kostas Pantopoulos, Lady Davis Institute for Medical Research/McGill University

10:30 - 10:45 AM
Coffee Break & Poster Sessions

10:45 - 12:25 PM
SYMPOSIUM ‑ STATE OF THE ART: HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA

Adam Gehring, UHN & Ebehard Renner, University of Manitoba

  • Differences in Clonal Evolution of Recurrent Hepatocellular Carinoma Depending on the Immune Environment, Mamatha Bhat, UHN
  • Current Status of Liver Transplantation for Cholangiocarcinoma/ Colorectal Metastases, Peter Metrakos, McGill University, Montreal, Canada
  • Oncolytic Viruses for Cancer Immunotherapy, Shashi Gujar, Dalhousie University
  • Barriers and Controversies in HCC Surveillance, Amit Singal, UT Southwestern Liver Centre
  • Systemic Therapy in HCC, Adrian di Bisceglie

12:25 - 1:15 PM
Gold Medal Lecture

1:15 - 1:45 PM
Closing Remarks and Awards